The United States Food and Drugs Administration (FDA), a federal agency of the United States Department of Health and Human Services, approves remdesivir as drug for emergency use in treatment of COVID-19.
Remdesivir is a broad spectrum antiviral drug that has shown effectiveness in both invitro and in vivo administration. Remdesivir was developed by Gilead Sciences.
Details later….